Kenney, Christopher John

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Kenney, Christopher John's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
83.38
Quantity 77,591 -30.1%
Value US$3,439,959
Transaction date
Sale
Price
473.06
Quantity 95,714
Value US$4,114,161
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-13
S Sale
77,591 -30.1%
83.38
US$3,439,959 		77,591 -30.1% 83.38 US$3,439,959
2023-03-24 2023-03-24
S Sale
95,714
473.06
US$4,114,161 		95,714 473.06 US$4,114,161